Table II.
Cellular Attributes Measured to Assess Cytotoxicity and Definition of Abnormality Threshold Used in the Data Analysis
# | Attributes | Definition of the abnormality threshold |
---|---|---|
1 | % non-adherent cells | (Mean cell number in well of untreated cells – mean cell number of wells with treated cells) / mean cell number in well of untreated cells) * 100 |
2 | Elevated mitochondrial activity | Single-cell fluorescence intensity (FI) of the mitochondrial activity stain in the treatment group is > 2 SD of the mean FI of the untreated population |
3 | Reduced mitochondrial activity | Single-cell FI of the mitochondrial activity stain in the treatment group is < 2 SD of the mean FI of the untreated population |
4 | Elevated membrane permeability | Single-cell FI of the membrane integrity stain in the treatment group is > 2 SD of the mean FI of the untreated population |
5 | Abnormal nuclear area | Single-cell area of the nuclear stain in the treatment group is either > or < 2 SD of the mean nuclear area of the untreated population |
6 | Elevated cellular area | Single-cell area of the cytoplasm stain in the treatment group is either > 2 SD of the mean cellular area of the untreated population |
7 | Polynucleated cells | (Mean number of polynucleated cells in untreated cells –number of polynucleated cells in well of treated cells) / mean number of polynucleated cells in untreated cells) * 100 |
8 | Elevated vacuole area | Single-cell area of the non-stained cytoplasm (vacuole space) in the treatment group > 2 SD of the area of the non-stained cytoplasm (vacuole space) of the untreated population |
9 | Elevated neutral lipids | Single-cell FI of the neutral lipid stain in the treatment group is > 2 SD of the mean FI of the untreated population |
10 | Elevated phospholipids | Single-cell FI of the phospholipid stain in the treatment group is > 2 SD of the mean FI of the untreated population |